TerrAscend Signs Agreement with Chain of 26 Clinics for Medical Cannabis Education and Support

Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

TerrAscend’s Wholly-Owned Subsidiary, Solace Health Network Inc., Announces Agreement with MCI Medical Clinics Inc. to Bring Medical Cannabis Expertise to Patients

TORONTO, Sept. 20, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) today announced that the Company’s wholly-owned subsidiary, Solace Health Network Inc. (“Solace Health Network”), has entered into an agreement with MCI Medical Clinics Inc. (“MCI”) to provide medical cannabis services.

Solace Health Network is a medical education and support program with a focus on patient care through quality medical cannabis education, patient services and cannabinoid treatment plans. MCI is one of the largest primary medical care groups in Canada with twenty-six clinics located across the country with over two million registered patients.

With Solace Health Network, patients have the option to meet with healthcare professionals and educators, either in-person or through a telehealth consultation from the convenience and privacy of a home environment.

Sabrina Ramkellawan, VP of Clinical Affairs at TerrAscend

We have been working on numerous cannabinoid research initiatives with the goal of building a body of evidence to guide clinical education and support. With this agreement, these services will now be available to MCI patients at their clinic network.

Under the terms of the agreement, Solace Health Network will become the exclusive partner for MCI, providing MCI patients with access to expertise, services and information, as well as ongoing clinical and reimbursement support. Solace Health Network offers specialized services to meet the evolving needs of patients, including condition-specific treatment plans to assist patients with dose and strain selection as well as guidance through wellness plans for non-pharmacological treatments.

“On behalf of our expansive patient clinics throughout Alberta and Ontario, we are delighted to have selected Solace Health Network as our partner to serve patients with medical cannabis services said Maddie Walker, President of MCI. “We are confident that their services of assessing, treating and managing patient needs for medical cannabis will provide an added and requested competency to our medical network.”

About TerrAscend

TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals.

Original press release

For fact-based information on TerrAscend, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter